What is Wolfe Research's price target for EW?

Wolfe Research's latest stated price target for Edwards Lifesciences Corporation (EW) is $92, from its action on Apr 1, 2026.

What is Wolfe Research's rating on EW?

Wolfe Research rates EW Outperform, a bullish rating, as of Apr 1, 2026.

When did Wolfe Research last change its view on EW?

On Apr 1, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $92.

Analyst firms · Wolfe Research · EW

Wolfe Research EW price target and rating history

Edwards Lifesciences Corporation (EW) · Health Care

Wolfe Research rates Edwards Lifesciences Corporation (EW) Outperform with a $92 price target, as of its latest action on Apr 1, 2026. It has published 6 rating actions on EW since April 2022, including 3 upgrades and 2 downgrades. Across 7 firms with a EW price target in the last 12 months, the median target is $110. Wolfe Research's $92 is 16% below that.

Current rating: Outperform
Price target: $92
Median target, all firms: $110
Actions on EW: 6

Wolfe Research price target on EW

Wolfe Research price target on EW, each point a stated target, April 2022 to April 2026.

Every Wolfe Research rating on EW

Apr 1, 2026
UpgradeWolfe Research upgrades to Outperform from Peer Perform, price target $92
Oct 29, 2025
UpgradeWolfe Research upgrades to Peer Perform from Underperform
Jan 16, 2025
DowngradeWolfe Research downgrades to Underperform from Peer Perform, price target $60
Jul 29, 2024
UpgradeWolfe Research upgrades to Peer Perform from Underperform
Nov 28, 2023
DowngradeWolfe Research downgrades to Underperform from Peer Perform, price target $57
Apr 6, 2022
InitiateWolfe Research starts coverage at Outperform, price target $134

How other firms rate EW

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Robert W. Baird	Outperform	$116	Nov 5, 2026
Truist Securities	Buy	$113	Nov 4, 2026
Barclays	Overweight	$110	Oct 7, 2026
UBS	Buy	$110	Jul 28, 2026
Leerink Partners	Outperform	$101	Jul 24, 2026
Wolfe Research	Outperform	$92	Apr 1, 2026
TD Cowen	Buy	$97	Jan 9, 2026

Questions about Wolfe Research and EW

What is Wolfe Research's price target for EW?: Wolfe Research's latest stated price target for Edwards Lifesciences Corporation (EW) is $92, from its action on Apr 1, 2026.
What is Wolfe Research's rating on EW?: Wolfe Research rates EW Outperform, a bullish rating, as of Apr 1, 2026.
When did Wolfe Research last change its view on EW?: On Apr 1, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $92.
How does Wolfe Research's EW target compare with other analysts?: Across 7 firms with a EW price target in the last 12 months, the median target is $110. Wolfe Research's $92 is 16% below that.

More EW rating histories

All Wolfe Research ratings EW news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.